A phase 2 randomized, double-blind, placebo-controlled, multicenter study of VS-6063 as maintenance therapy in subjects with malignant pleural mesothelioma which has not progressed on at least 4 cycles of pemetrexed/platinum therapy Meeting Abstract
| Authors: | Keegan, M.; Baas, P.; Fennell, D.; Gralla, R. J.; Kindler, H.; Krug, L. M.; Nowak, A. K.; Schwartz, L. H.; Horobin, J. C. |
| Abstract Title: | A phase 2 randomized, double-blind, placebo-controlled, multicenter study of VS-6063 as maintenance therapy in subjects with malignant pleural mesothelioma which has not progressed on at least 4 cycles of pemetrexed/platinum therapy |
| Meeting Title: | 15th World Conference on Lung Cancer (IASLC) |
| Keywords: | mesothelioma; cancer stem cells; fak; nf2/merlin |
| Journal Title: | Journal of Thoracic Oncology |
| Volume: | 8 |
| Issue: | Suppl. 2 |
| Meeting Dates: | 2013 Oct 27-31 |
| Meeting Location: | Sydney, Australia |
| ISSN: | 1556-0864 |
| Publisher: | Elsevier Inc. |
| Date Published: | 2013-11-01 |
| Start Page: | S941 |
| End Page: | S942 |
| Language: | English |
| ACCESSION: | WOS:000339624904247 |
| PROVIDER: | wos |
| DOI: | 10.1097/01.JTO.0000438438.14562.c8 |
| Notes: | Meeting Abstract: P2.14-014 -- Source: Wos |
